Suchergebnisse - "Best, Jennie H"

PubPharm (3)

1

Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States : results from a retrospective claims database analysis

enthalten in: Journal of medical economics | 2012

von Pelletier, E. | Pawaskar, M. | Smith, P. | +2

2

Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States

enthalten in: Journal of medical economics | 2012

von Guillermin, A. | Lloyd, A. | Best, J. | +3

3

Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US

enthalten in: Journal of medical economics | 2012

von Samyshkin, Y. | Guillermin, A. | Best, J. | +2

1
[1]